These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1254 related articles for article (PubMed ID: 9233789)

  • 1. beta-catenin is a target for the ubiquitin-proteasome pathway.
    Aberle H; Bauer A; Stappert J; Kispert A; Kemler R
    EMBO J; 1997 Jul; 16(13):3797-804. PubMed ID: 9233789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45.
    Hagen T; Vidal-Puig A
    Biochem Biophys Res Commun; 2002 Jun; 294(2):324-8. PubMed ID: 12051714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential interaction of plakoglobin and beta-catenin with the ubiquitin-proteasome system.
    Sadot E; Simcha I; Iwai K; Ciechanover A; Geiger B; Ben-Ze'ev A
    Oncogene; 2000 Apr; 19(16):1992-2001. PubMed ID: 10803460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.
    Bonvini P; An WG; Rosolen A; Nguyen P; Trepel J; Garcia de Herreros A; Dunach M; Neckers LM
    Cancer Res; 2001 Feb; 61(4):1671-7. PubMed ID: 11245482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
    Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A
    EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression.
    Jho Eh; Lomvardas S; Costantini F
    Biochem Biophys Res Commun; 1999 Dec; 266(1):28-35. PubMed ID: 10581160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttranscriptional regulation of alpha-catenin expression is required for Wnt signaling in L cells.
    Takahashi N; Ishihara S; Takada S; Tsukita S; Nagafuchi A
    Biochem Biophys Res Commun; 2000 Nov; 277(3):691-8. PubMed ID: 11062015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axin prevents Wnt-3a-induced accumulation of beta-catenin.
    Kishida M; Koyama S; Kishida S; Matsubara K; Nakashima S; Higano K; Takada R; Takada S; Kikuchi A
    Oncogene; 1999 Jan; 18(4):979-85. PubMed ID: 10023673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of beta-catenin by activated p53.
    Sadot E; Geiger B; Oren M; Ben-Ze'ev A
    Mol Cell Biol; 2001 Oct; 21(20):6768-81. PubMed ID: 11564862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WNT-1 and HGF regulate GSK3 beta activity and beta-catenin signaling in mammary epithelial cells.
    Papkoff J; Aikawa M
    Biochem Biophys Res Commun; 1998 Jun; 247(3):851-8. PubMed ID: 9647782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.
    Wei Y; Fabre M; Branchereau S; Gauthier F; Perilongo G; Buendia MA
    Oncogene; 2000 Jan; 19(4):498-504. PubMed ID: 10698519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of two novel regulated serines in the N terminus of beta-catenin.
    van Noort M; van de Wetering M; Clevers H
    Exp Cell Res; 2002 Jun; 276(2):264-72. PubMed ID: 12027456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.
    Ikeda S; Kishida M; Matsuura Y; Usui H; Kikuchi A
    Oncogene; 2000 Jan; 19(4):537-45. PubMed ID: 10698523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.
    Fishman P; Madi L; Bar-Yehuda S; Barer F; Del Valle L; Khalili K
    Oncogene; 2002 Jun; 21(25):4060-4. PubMed ID: 12037688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3.
    Christian SL; Sims PV; Gold MR
    J Immunol; 2002 Jul; 169(2):758-69. PubMed ID: 12097378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A.
    Seeling JM; Miller JR; Gil R; Moon RT; White R; Virshup DM
    Science; 1999 Mar; 283(5410):2089-91. PubMed ID: 10092233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of beta-catenin levels and localization by overexpression of plakoglobin and inhibition of the ubiquitin-proteasome system.
    Salomon D; Sacco PA; Roy SG; Simcha I; Johnson KR; Wheelock MJ; Ben-Ze'ev A
    J Cell Biol; 1997 Dec; 139(5):1325-35. PubMed ID: 9382877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin.
    Kitagawa M; Hatakeyama S; Shirane M; Matsumoto M; Ishida N; Hattori K; Nakamichi I; Kikuchi A; Nakayama K; Nakayama K
    EMBO J; 1999 May; 18(9):2401-10. PubMed ID: 10228155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ubiquitin-proteasome pathway and serine kinase activity modulate adenomatous polyposis coli protein-mediated regulation of beta-catenin-lymphocyte enhancer-binding factor signaling.
    Easwaran V; Song V; Polakis P; Byers S
    J Biol Chem; 1999 Jun; 274(23):16641-5. PubMed ID: 10347231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of S33/S37 phosphorylated beta-catenin in normal and transformed cells.
    Sadot E; Conacci-Sorrell M; Zhurinsky J; Shnizer D; Lando Z; Zharhary D; Kam Z; Ben-Ze'ev A; Geiger B
    J Cell Sci; 2002 Jul; 115(Pt 13):2771-80. PubMed ID: 12077367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.